Phillip A. Sharp
Massachusetts Institute of Technology · Biology
Active 1968–2025
Academic metrics are sourced from OpenAlex and public funding records; values may differ from Google Scholar.
About
Phillip A. Sharp is an Institute Professor and Professor of Biology Emeritus at MIT, affiliated with the Koch Institute for Integrative Cancer Research. His research has focused on various aspects of gene expression in mammalian cells, including transcription, the roles of non-coding RNAs such as microRNAs, and RNA splicing. He has investigated small, non-coding RNAs called microRNAs (miRNAs), which regulate over half of the genes in mammalian cells at the stages of translation and mRNA stability. Additionally, his work explores the processes underlying transcription from the anti-sense strand, known as divergent transcription, as well as the relationship between transcription elongation, RNA splicing, and chromatin modifications. Throughout his career, Sharp has made significant contributions to understanding gene regulation mechanisms and has been recognized with numerous awards, including the Nobel Prize in Physiology or Medicine in 1993, the National Medal of Science in 2004, and the AACR Award for Lifetime Achievement in Cancer Research in 2020.
Research topics
- Biology
- Genetics
- Computer Science
- Biophysics
- Internal medicine
- Medicine
- Physics
- Cell biology
- Computational biology
Selected publications
RNA-Mediated Feedback Control of Transcriptional Condensates
Cell · 2020 · 614 citations
Partitioning of cancer therapeutics in nuclear condensates
Science · 2020 · 517 citations
The nucleus contains diverse phase-separated condensates that compartmentalize and concentrate biomolecules with distinct physicochemical properties. Here, we investigated whether condensates concentrate small-molecule cancer therapeutics such that their pharmacodynamic properties are altered. We found that antineoplastic drugs become concentrated in specific protein condensates in vitro and that this occurs through physicochemical properties independent of the drug target. This behavior was als…
RNA in formation and regulation of transcriptional condensates
RNA · 2021-11-12 · 139 citations
reviewOpen access1st authorMacroscopic membraneless organelles containing RNA such as the nucleoli, germ granules, and the Cajal body have been known for decades. These biomolecular condensates are liquid-like bodies that can be formed by a phase transition. Recent evidence has revealed the presence of similar microscopic condensates associated with the transcription of genes. This brief article summarizes thoughts about the importance of condensates in the regulation of transcription and how RNA molecules, as components…
Single-cell nascent RNA sequencing unveils coordinated global transcription
Nature · 2024-06-05 · 108 citations
articleOpen accessSenior authorAbstract Transcription is the primary regulatory step in gene expression. Divergent transcription initiation from promoters and enhancers produces stable RNAs from genes and unstable RNAs from enhancers 1,2 . Nascent RNA capture and sequencing assays simultaneously measure gene and enhancer activity in cell populations 3 . However, fundamental questions about the temporal regulation of transcription and enhancer–gene coordination remain unanswered, primarily because of the absence of a single-ce…
Oncogenic <i>CDK13</i> mutations impede nuclear RNA surveillance
Science · 2023-04-20 · 53 citations
articleOpen accessRNA surveillance pathways detect and degrade defective transcripts to ensure RNA fidelity. We found that disrupted nuclear RNA surveillance is oncogenic. Cyclin-dependent kinase 13 ( CDK13 ) is mutated in melanoma, and patient-mutated CDK13 accelerates zebrafish melanoma. CDK13 mutation causes aberrant RNA stabilization. CDK13 is required for ZC3H14 phosphorylation, which is necessary and sufficient to promote nuclear RNA degradation. Mutant CDK13 fails to activate nuclear RNA surveillance, caus…
Recent grants
NIH · $9.9M · 1984–2022
Stress and Proliferation States Impact MicroRNA-Mediated Regulation in Cancer
NIH · $4.6M · 2008–2019
NIH · $8.9M · 2016
Frequent coauthors
- 236 shared
C. Collard
Institut Pluridisciplinaire Hubert Curien
- 235 shared
J. Andreä
Institut Pluridisciplinaire Hubert Curien
- 234 shared
E. Conte
Institut Pluridisciplinaire Hubert Curien
- 232 shared
D. Blöch
Institut Pluridisciplinaire Hubert Curien
- 221 shared
E. C. Chabert
Institut Pluridisciplinaire Hubert Curien
- 212 shared
M. Lethuillier
Institute of Nuclear Physics of Lyon
- 191 shared
B. Ille
Institute of Nuclear Physics of Lyon
- 190 shared
P. Verdier
Institute of High Energy Physics
Labs
Phillip A. Sharp LabPI
Awards & honors
- AACR Award for Lifetime Achievement in Cancer Research (2020…
- AACR Distinguished Award for Extraordinary Scientific Innova…
- Royal Society of London, Foreign Fellow (2011)
- National Science Foundation, National Medal of Science (2004…
- The Nobel Foundation, Nobel Prize in Physiology or Medicine…
Similar researchers at Massachusetts Institute of Technology
- Resume-aware match score
- Save to shortlist
- AI-drafted outreach
See your match with Phillip A. Sharp
PhdFit ranks faculty by your research interests, methods, and publications — grounded in their actual work, not templates.
- Free to start
- No credit card
- 30-second signup
